Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
AMERICAN BIO MEDICA CORP (ABMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2023 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
06/29/2022 8-K Quarterly results
03/14/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
12/22/2021 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from UHY, LLP addressed to the United States Securities & Exchange Commission"
11/18/2021 8-K Quarterly results
Docs: "ABMC REPORTS THIRD QUARTER 2021 RESULTS Kinderhook, N.Y., November 18, 2021 – American Bio Medica Corporation today announced financial results for the three and nine months ended September 30, 2021. Chief Executive Officer Melissa A. Waterhouse stated, “We are encouraged by the fact that when compared to the second quarter 2021, sales actually increased 16.1% in the third quarter 2021. This increase is a result of our drug testing markets continuing to return to normal, increased contract manufacturing sales from our current customers, stabilized clinical sales and higher sales of rapid Covid-19 tests as a result of new products we started to offer within the last few months. At the end of the third quarter, we had open sales orders of ABMC drug tests in the amount of $336,000 due to cont..."
08/18/2021 8-K Quarterly results
06/29/2021 8-K Quarterly results
05/20/2021 8-K Quarterly results
04/15/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
02/11/2021 8-K Quarterly results
12/21/2020 8-K Submission of Matters to a Vote of Security Holders
12/10/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Purchase Agreement dated December 8, 2020, by and between American Bio Medica Corporation and Lincoln Park Capital Fund, LLC",
"Registration Rights Agreement dated December 8, 2020, by and between American Bio Medica Corporation and Lincoln Park Capital Fund, LLC",
"ABMC ANNOUNCES COMMON STOCK PURCHASE AGREEMENT FOR UP TO $10M WITH LINCOLN PARK CAPITAL FUND, LLC"
11/16/2020 8-K Quarterly results
Docs: "ABMC REPORTS THIRD QUARTER 2020 RESULTS --Announces Application to Up-List to OTCQB-- Kinderhook, N.Y., November 16, 2020 – American Bio Medica Corporation today announced financial results for the three and nine months ended September 30, 2020 and announced they have applied to up-list its common stock to the OTCQB® Venture Marketplace. Chief Executive Officer Melissa A. Waterhouse stated, “As Covid-19 infections started to rise in the third quarter, the market turned to diagnostic testing, and we saw a decrease in demand for antibody testing. While there can be no assurances, we believe that antibody testing will become increasingly necessary with the emergence of vaccines. In October, we signed a distribution agreement to sell the Co-Diagnostics, Inc. Logix™ Smart Cov..."
09/15/2020 8-K Quarterly results
Docs: "ABMC REPORTS SECOND QUARTER 2020 RESULTS Kinderhook, N.Y., September 15, 2020 – American Bio Medica Corporation today announced financial results for the three and six months ended June 30, 2020. Chief Executive Officer Melissa A. Waterhouse stated, “We are pleased to report increased sales when comparing 2020 to 2019 as a result of our distribution of the Covid-19 antibody test. There are a number of sales opportunities for the Covid-19 test in the pipeline and marketing applications yet to come for the product. In the meantime, it has been well received by customers. From an operational perspective, selling and marketing expense increased , however, all other expenses decreased in the second quarter of 2020 even with increased sales. This allowed us to achieve operating income in ..."
08/20/2020 8-K Quarterly results
07/31/2020 8-K Quarterly results
06/26/2020 8-K Quarterly results
06/02/2020 8-K Regulation FD Disclosure
05/14/2020 8-K Other Events
03/23/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "ABMC OFFERS RAPID TEST FOR COVID-19 --Company expects distribution would materially impact sales-- Kinderhook, N.Y., March 20, 2020 – American Bio Medica Corporation , a manufacturer of accurate, cost-effective immunoassay test kits, announced today that it began offering on March 17, 2020, via a distribution partnership, a Rapid Test to detect Covid-19 in whole blood, serum or plasma. The assay offers qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus and provides results in as few as 2 minutes and generally not more than 15 minutes. The test has not yet been reviewed by the U.S. Food and Drug Administration , but is being offered under the March 16, 2020 guidance set forth by the FDA. The test can be used for rapid screening of carriers of the ..."
02/25/2020 8-K Quarterly results
01/10/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2019 8-K Quarterly results
08/14/2019 8-K Quarterly results
Docs: "ABMC REPORTS SECOND QUARTER 2019 RESULTS Kinderhook, N.Y., August 14, 2019 – American Bio Medica Corporation today announced financial results for the three and six months ended June 30, 2019. Chief Executive Officer Melissa A. Waterhouse stated, “We are pleased that the second quarter of 2019 was our second consecutive quarter of increased sales. While sales are down when comparing prior periods, we are hopeful that we are on the right track to reversing that trend. Our contract business continues to grow and we expect this will positively impact sales in the second half of 2019. In addition to these new customers, we are exploring a number of other potential sales opportunities.” Waterhouse continued, “We are currently exploring options to refinance current debt give..."
06/21/2019 8-K Submission of Matters to a Vote of Security Holders
05/24/2019 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "ABMC ORAL FLUID CONSENT DECREE VACATED --Company will re-enter the employment market with oral fluid drug tests-- Kinderhook, N.Y., May 20, 2019 – American Bio Medica Corporation announced today that on May 23, 2019, its Consent Decree of Permanent Injunction with the U.S. Food and Drug Administration has been vacated and the case has been closed. This action resolves a long-standing inability of the Company to market and sell oral fluid drug tests in the employment market. The Company is now allowed to sell oral fluid drugs tests in the employment and insurance markets under a limited exemption set forth by the FDA on July 11, 2017. Notwithstanding the Consent Decree , the Company, through FDA audits, has remained fully compliant with cGMP regulations. Chief Executive Officer Melissa A. W..."
05/20/2019 8-K Quarterly results
Docs: "ABMC REPORTS FIRST QUARTER 2019 RESULTS Kinderhook, N.Y., May 20, 2019 – American Bio Medica Corporation today announced financial results for the three months ended March 31, 2019. Chief Executive Officer Melissa A. Waterhouse stated, “New contract manufacturing sales and increased sales of products offered through distribution relationships partially offset lost government sales in the first quarter 2019 when compared to the first quarter 2018. International sales were also down in the first quarter 2019; most of which we believe is due to timing of orders. Expenses remained in line with sales and this allowed us to report a slight improvement in result from operations.” Financial Highlights ● Net sales in the first quarter 2019 were $923,000, compared to net sales o..."
04/16/2019 8-K Quarterly results
03/01/2019 8-K Quarterly results
12/26/2018 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "FORM OF SECURITIES PURCHASE AGREEMENT"
06/26/2018 8-K Submission of Matters to a Vote of Security Holders
03/08/2018 8-K Entry into a Material Definitive Agreement
01/11/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy